Association of endothelin with lung hemorrhage induced by immune complexes in rats

Inflammation

Volumn 28, Issue 5, 2004, Pages 253-261

  Teixeira, C F P ^a   Jancar, S ^b   Lima, W T ^b   D'Orleans Juste P ^c   Sirois, P ^c  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

BN52021; BQ 123; BQ 788; Endothelins; Immune complex; L NAME; Lung hemorrhage

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; GINKGOLIDE B; HEMOGLOBIN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; OVALBUMIN; THIORPHAN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTHUS PHENOMENON; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRAVASATION; LUNG HEMORRHAGE; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; NONHUMAN; RADIOIMMUNOASSAY; RAT;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ARTHUS REACTION; BRONCHOALVEOLAR LAVAGE FLUID; DITERPENES; ENDOTHELINS; FIBRINOLYTIC AGENTS; GINKGOLIDES; HEMOGLOBINS; HEMORRHAGE; LACTONES; LUNG DISEASES; MALE; NEUTROPHILS; OLIGOPEPTIDES; OVALBUMIN; PEPTIDES, CYCLIC; PIPERIDINES; PNEUMONIA; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 23944492605     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-004-6048-x     Document Type: Article

References (54)

1. Rubanyi, G. M., and M. A. Polokoff. 1994. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and physiopathology. Pharmacol. Rev. 46:325-415.
2. Tsuji, S., A. Sawamura, H. Watanabe, K. Takihara, S. E. Park, and J. Azuma. 1991. Plasma endothelin levels during myocardial ischemia and reperfusion. Life Sci. 48:1745-1749.
3. Battistini, B., M. A. Forget, and D. Laight. 1996. Potential roles for endothelins in systemic inflammatory response to syndrome with a particular relationship to cytokines. Shock 5:167-183.
4. Simmet, T., S. Pritze, K. I. Thelen, and B. A. Peskar. 1992. Release of endothelin in the oleic acid-induced respiratory distress syndrome in rats. Eur. J. Pharmacol. 211:319-322.
5. Filep, J. G. 1993. Endothelin peptides: biological actions and pathophysiological significance in the lung. Life Sci. 52:119-133.
6. Barnes, P. J. 1994. Endothelins and pulmonary disease. J. Appl. Physiol. 77:1051-1059.
7. Hay, D., P. J. Henry, and R. G. Goldie. 1993. Endothelin and the respiratory system. Trends Pharmacol. Sci. 14:29-32.
8. Filep, J. G., M. G. Sirois, A. Rousseau, A. Fournier, and P. Sirois. 1991. Effects of endothelin-1 on vascular permeability in the conscious rat: Interactions with platelet-activating factor. Br. J. Pharmacol. 104:797-804.
9. Helset, E., J. Kjaeve, and A. Hauge. 1993. Endothelin-1-induced increases in microvascular permeability is isolated, perfused rat lungs requires leukocytes and plasma. Circ. Shock 39:15-20.
10. Helset, E., T. Ytrehus, T. Tveita, J. Kjaeve, and L. Jorgensen. 1994. Endothelin-1 causes accumulation of leukocytes in the pulmonary circulation. Circ. Shock 44:201-209.
11. Helset, E., S. Lindal, R. Olsen, R. Myklebust, and L. Jorgensen. 1996. Endothelin-1 causes sequential trapping of platelets and neutrophils in pulmonary microcirculation in rats. Am. J. Physiol. 271:L538-L546.
12. Boros, M., S. Massberg, L. Baranyi, and H. Okada. 1998. Endothelin 1 induced leukocytes adhesion in submucosal venules of the rat small intestine. Gastroenterology 114:103-114.
13. Lopez Farré, A., A. Riesco, G. Espinosa, E. Diguini, M. R. Cernadas, V. Alvarez, M. Morton, F. Rivas, M. J. Gallego, J. Egido, S. Casado, and C. Caramelo. 1993. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 88:1166-1171.
14. McCarron, R. M., L. Wang, D. B. Stanimirovic, and M. Spatz. 1993. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci. Lett. 156:31-34.
15. Boichot, E., V. Lagente, J. M. Mencia-Huerta, and P. Braquet. 1993. Bronchopulmonary response to endothelin-1 in sensitized and challenged guinea-pigs: role of cyclooxygenase metabolites and platelet-activating factor. Fundamental Clin. Pharmacol. 7:281-291.
16. Nomura, A., Y. Uchida, M. Kameyana, M. Saotome, K, and S. Hasegawa. 1989. Endothelin and bronchial asthma (letter). Lancet 2:747-748.
17. Mattoli, S., M. Soloperto, M. Marini, and A. Fasoli. 1991. Levels of endothelin in the bronchoalveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J. Allergy Clin. Immunol. 88:376-384.
18. Lima, W. T., P. Sirois, and S. Jancar. 1992. Immune-complex alveolitis in the rat: Evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions. Eur. J. Pharmacol. 213:63-70.
19. Mulligan, M. S., S. Moncada, and P. A. Ward. 1992. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br. J. Pharmacol. 107:1159-1162.
20. Lima, W. T., A. A. Steil, M. Russo, N. Starobinas, C. F. P. Teixeira, and S. Jancar, 1998. Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury. Eur. J. Pharmacol. 358:69-75.
21. Ihara, M., K. Noguchi, T. Saeki, T. Fukuroda, S. Tsuchida, S. Kimura, T. Fukami, K. Ishikawa, M. Nishikibe, and M. Yano. 1992. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 50:247-255.
22. Ishikawa, K., M. Ihara, K. Noguchi, T. Mase, N. Mino, T Saeki, T. Fukuroda, T. Fukami, T. Ozaki, T. Nagase, M. Nichikibe, and M. Yano. 1992. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U.S.A. 89:6886-6890.
23. Braquet, P. 1987. The ginkgolides: Potent platelet-activating factor antagonists isolated from Ginkgo biloba L.: Chemistry, pharmacology and clinical applications. Drugs Future 12:643-699.
24. VanKampen, E. J., and W. G. Zilstra. 1962. Standardization of hemoglobinometry. II. The hemoglobincyanide method. Clin. Chim. Acta. 6:538-544.
25. Sokal, R. R., and F. J. Rohlf. 1981. Biometry, 2nd edn., W. H. Freeman, New York, 859 pp.
26. Schwartz, J. C., C. Gros, F. M. Lecomte, and J. Bralet. 1990. Enkephalinase (EC 3.4.24.11) inhibitors: protection of endogenous ANF against inactivation and potential therapeutic applications. Life Sci. 47:1279-1297.
27. Chakir, M., P. D'orléans-Juste, and G. Plante. 1995. Neutral endopeptidase inhibition, a new approach in the exploration of diabetic vasculopathy in rats. Eur. J. Pharmacol. 285:11-18.
28. Andersson, S. E., A. Hemsen, C. Zackrisson, and J. M. Lundberg. 1996. Release of endothelin-1 into rat airways following Sephadex-induced inflammation. Modulation by enzyme inhibitors and butesodine. Respiration 63:111-116.
29. Stelzner, T. J., R. F. O'Brien, M. Yanagisawa, T. Sakurai, K. Sato, S. Wenn, M. Zamora, I. F. McMurtry, and J. H. Fisher. 1992. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am. J. Physiol. 262:614-620.
30. Rosengurt, N., D. R. Springel, and J. M. Polak. 1990. Localization of endothelin-like immunoreactivity in airway epithelium of rats and mice. J. Pathol. 160:5-8.
31. Markewitz, B. A., D. E. Kohan, and J. R. Michael. 1995. Endothelin-1 synthesis, receptors, and signal transduction in alveolar epithelium - Evidence for an autocrine role. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 268:L192-L200.
32. Ehrennreich, H., R. W. Anderson, C. H. Fox, P. Rieckmann, G. S. Hoffmann, W. P. Travis, J. E. Coligan, J. H. Kehrl, and A. S. Fauci. 1990. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J. Exp. Med. 172:1741-1748.
33. Kobayashi, Y., Y. Sakamoto, M. Shibasaki, I. Kimura, and H. Matsuo. 1997. Human alveolar macrophages synthesize endothelins by thrombin. J. Immunol. 158:5442-5447.
34. Sessa, W. C., S. Kaw, M. Hecker, and J. R. Vane. 1991. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 174:613-618.
35. Kaw, S., M. Hecker, and J. R. Vane. 1992. The two-step conversion of big-endothelin-1 to endothelin-1 and degradation of endothelin-1 by subcellular fractions from human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. U.S.A. 89:6886-6890.
36. Yamaguchi, T., H. Kohrogi, O. Kawano, M. Ando, and S. Araki. 1992. Neutral endopeptidase inhibitor potentiates endothelin-1-induced airway smooth muscle contraction. J. Appl. Physiol. 73:1108-1113.
37. Nadel, J. A. 1990. Decreased neutral endopeptidases: Possible role in inflammatory diseases of airways. Lung 168:123-127.
38. Abassi, Z., E. Golomb, and H. R. Keiser. 1992. Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelin. Metabolism 41:683-685.
39. Shimada, K., M. Takahashi, and K. Tanzana. 1994. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J. Biol. Chem. 269:18275-18278.
40. Ferro, C. J., J. C. Spratt, W. G. Haynes, and D. J. Webb. 1998. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo. Circulation 97:2323-2330.
41. Ando, S., M. A. Rahman, G. C. Butler, B. L. Senn, and J. S. Floras. 1995. Comparison of candoxatril and atrial natriuretic factor in healthy men: Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin. Hypertension 26:1160-1166.
42. Sirois, M. G., J. G. Filep, A. Rousseau, A. Fournier, G. E. Plante, and P. Sirois. 1992. Endothelin-1 enhances vascular permeability in conscious rats: Role of TXA2. Eur. J. Pharmacol. 214:119-125.
43. Henriques, M. G., G. A. Rae, R. S. Cordeiro, and T. J. Williams. 1992. Endothelin-1 inhibits PAF-induced paw edema and pleurisy in the mouse. Br. J. Pharmacol. 106:579-582.
44. De Nucci, G., R. J. Gryglewski, T. D. Warner, and J. R. Vane. 1988. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc. Natl. Acad. Sci. U.S.A. 85:2334-2338.
45. Ishida, K., K. Takeshige, and S. Minakami. 1990. Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem. Biophys. Res. Commun. 173:496-500.
46. Hafström, I., B. Ringertz, T. Lundenberg, and J. Palmblad. 1993. The effect of endothelin, neuropeptide Y, calcitonin gene-related peptide and substance P on neutrophil functions. Acta Physiol. Scand. 148:341-346.
47. Wright, C. D., W. L. Cody, J. B. Dunbar, Jr., A. M. Doherty, G. P. Hingorani, and S. T. Rrapundalo. 1994. Characterisation of endothelins as chemoattractants for human neutrophils. Life Sci. 55:1633-1641.
48. Elferink, J. G. R., and B. M. Koster. 1995. Stimulation and inhibition of neutrophil chemotaxis by ET-3. Cardiovasc. Pharmacol. 26(Suppl. 3):S142-S144.
49. Bonvallet, S. T., M. Oka, M. Yano, M. R. Zamora, I. F. Mcmurtry, and T. J. Stelzner. 1993. BQ-123, and ETA receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation. J. Cardiovasc. Pharmacol. 22:39-43.
50. Lal, H., B. Woodward, and K. I. Wiliams. 1995. Actions of endothelins and sarafotoxin 6c in the rat isolated perfused lung. Br. J. Pharmacol. 115:653-659.
51. 125I-endothelin in rat kidney and lung examined by electron microscopic authoradiography. Anat. Embriol. 185:87-96.
52. B receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J. Cardiovasc. Pharmacol. 23:838-845.
53. Goldie, R. G., A. C. D'aprile, G. J. Self, P. J. Rigby, and P. J. Henry. 1996. The distribution and density of receptor subtypes for endothelin-1 in peripheral lung of the rat, guinea-pig and pig. Br. J. Pharmacol. 117:729-735.
54. A) receptors in ovine airway smooth muscle and their meditation of ET-1-induced contraction. Br. J. Pharmacol. 112:749-756.